0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plasma Fractionation and Blood Product Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-27F8187
Home | Market Reports | Health| Pharmacy
Global Plasma Fractionation and Blood Product Market Insights and Forecast to 2028
BUY CHAPTERS

Global Plasma Fractionation and Blood Product Market Research Report 2025

Code: QYRE-Auto-27F8187
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Plasma Fractionation and Blood Product Market Size

The global market for Plasma Fractionation and Blood Product was valued at US$ 5060 million in the year 2024 and is projected to reach a revised size of US$ 6122 million by 2031, growing at a CAGR of 2.8% during the forecast period.

Plasma Fractionation and Blood Product Market

Plasma Fractionation and Blood Product Market

Human blood plasma is nature"s raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Plasma Fractionation and Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Fractionation and Blood Product.
The Plasma Fractionation and Blood Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasma Fractionation and Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Fractionation and Blood Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Plasma Fractionation and Blood Product Market Report

Report Metric Details
Report Name Plasma Fractionation and Blood Product Market
Accounted market size in year US$ 5060 million
Forecasted market size in 2031 US$ 6122 million
CAGR 2.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Plasma Fractionation and Blood Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Plasma Fractionation and Blood Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Plasma Fractionation and Blood Product Market growing?

Ans: The Plasma Fractionation and Blood Product Market witnessing a CAGR of 2.8% during the forecast period 2025-2031.

What is the Plasma Fractionation and Blood Product Market size in 2031?

Ans: The Plasma Fractionation and Blood Product Market size in 2031 will be US$ 6122 million.

Who are the main players in the Plasma Fractionation and Blood Product Market report?

Ans: The main players in the Plasma Fractionation and Blood Product Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio

What are the Application segmentation covered in the Plasma Fractionation and Blood Product Market report?

Ans: The Applications covered in the Plasma Fractionation and Blood Product Market report are Immunology, Hematology, Other

What are the Type segmentation covered in the Plasma Fractionation and Blood Product Market report?

Ans: The Types covered in the Plasma Fractionation and Blood Product Market report are Coagulation Factor, Immune Globulin, Albumin, Other

Recommended Reports

Blood Products Market

Blood Purification Devices

Blood Analysis & Collection

1 Plasma Fractionation and Blood Product Market Overview
1.1 Product Definition
1.2 Plasma Fractionation and Blood Product by Type
1.2.1 Global Plasma Fractionation and Blood Product Market Value Comparison by Type (2024 VS 2031)
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Other
1.3 Plasma Fractionation and Blood Product by Application
1.3.1 Global Plasma Fractionation and Blood Product Market Value by Application (2024 VS 2031)
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Other
1.4 Global Plasma Fractionation and Blood Product Market Size Estimates and Forecasts
1.4.1 Global Plasma Fractionation and Blood Product Revenue 2020-2031
1.4.2 Global Plasma Fractionation and Blood Product Sales 2020-2031
1.4.3 Global Plasma Fractionation and Blood Product Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Plasma Fractionation and Blood Product Market Competition by Manufacturers
2.1 Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2020-2025)
2.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Plasma Fractionation and Blood Product Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Plasma Fractionation and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Plasma Fractionation and Blood Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma Fractionation and Blood Product, Product Type & Application
2.7 Global Key Manufacturers of Plasma Fractionation and Blood Product, Date of Enter into This Industry
2.8 Global Plasma Fractionation and Blood Product Market Competitive Situation and Trends
2.8.1 Global Plasma Fractionation and Blood Product Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Plasma Fractionation and Blood Product Players Market Share by Revenue
2.8.3 Global Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Plasma Fractionation and Blood Product Market Scenario by Region
3.1 Global Plasma Fractionation and Blood Product Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Plasma Fractionation and Blood Product Sales by Region: 2020-2031
3.2.1 Global Plasma Fractionation and Blood Product Sales by Region: 2020-2025
3.2.2 Global Plasma Fractionation and Blood Product Sales by Region: 2026-2031
3.3 Global Plasma Fractionation and Blood Product Revenue by Region: 2020-2031
3.3.1 Global Plasma Fractionation and Blood Product Revenue by Region: 2020-2025
3.3.2 Global Plasma Fractionation and Blood Product Revenue by Region: 2026-2031
3.4 North America Plasma Fractionation and Blood Product Market Facts & Figures by Country
3.4.1 North America Plasma Fractionation and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Plasma Fractionation and Blood Product Sales by Country (2020-2031)
3.4.3 North America Plasma Fractionation and Blood Product Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Plasma Fractionation and Blood Product Market Facts & Figures by Country
3.5.1 Europe Plasma Fractionation and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Plasma Fractionation and Blood Product Sales by Country (2020-2031)
3.5.3 Europe Plasma Fractionation and Blood Product Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma Fractionation and Blood Product Market Facts & Figures by Region
3.6.1 Asia Pacific Plasma Fractionation and Blood Product Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2020-2031)
3.6.3 Asia Pacific Plasma Fractionation and Blood Product Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Plasma Fractionation and Blood Product Market Facts & Figures by Country
3.7.1 Latin America Plasma Fractionation and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Plasma Fractionation and Blood Product Sales by Country (2020-2031)
3.7.3 Latin America Plasma Fractionation and Blood Product Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasma Fractionation and Blood Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2020-2031)
3.8.3 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plasma Fractionation and Blood Product Sales by Type (2020-2031)
4.1.1 Global Plasma Fractionation and Blood Product Sales by Type (2020-2025)
4.1.2 Global Plasma Fractionation and Blood Product Sales by Type (2026-2031)
4.1.3 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2020-2031)
4.2 Global Plasma Fractionation and Blood Product Revenue by Type (2020-2031)
4.2.1 Global Plasma Fractionation and Blood Product Revenue by Type (2020-2025)
4.2.2 Global Plasma Fractionation and Blood Product Revenue by Type (2026-2031)
4.2.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2020-2031)
4.3 Global Plasma Fractionation and Blood Product Price by Type (2020-2031)
5 Segment by Application
5.1 Global Plasma Fractionation and Blood Product Sales by Application (2020-2031)
5.1.1 Global Plasma Fractionation and Blood Product Sales by Application (2020-2025)
5.1.2 Global Plasma Fractionation and Blood Product Sales by Application (2026-2031)
5.1.3 Global Plasma Fractionation and Blood Product Sales Market Share by Application (2020-2031)
5.2 Global Plasma Fractionation and Blood Product Revenue by Application (2020-2031)
5.2.1 Global Plasma Fractionation and Blood Product Revenue by Application (2020-2025)
5.2.2 Global Plasma Fractionation and Blood Product Revenue by Application (2026-2031)
5.2.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2020-2031)
5.3 Global Plasma Fractionation and Blood Product Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Plasma Fractionation and Blood Product Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Plasma Fractionation and Blood Product Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Grifols Plasma Fractionation and Blood Product Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Plasma Fractionation and Blood Product Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Company Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Kedrion Plasma Fractionation and Blood Product Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Company Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.6.4 LFB Group Plasma Fractionation and Blood Product Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.7.1 Biotest Company Information
6.7.2 Biotest Description and Business Overview
6.7.3 Biotest Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biotest Plasma Fractionation and Blood Product Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Company Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BPL Plasma Fractionation and Blood Product Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Company Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.9.4 RAAS Plasma Fractionation and Blood Product Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Company Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CBPO Plasma Fractionation and Blood Product Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Company Information
6.11.2 Hualan Bio Description and Business Overview
6.11.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hualan Bio Plasma Fractionation and Blood Product Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma Fractionation and Blood Product Industry Chain Analysis
7.2 Plasma Fractionation and Blood Product Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma Fractionation and Blood Product Production Mode & Process Analysis
7.4 Plasma Fractionation and Blood Product Sales and Marketing
7.4.1 Plasma Fractionation and Blood Product Sales Channels
7.4.2 Plasma Fractionation and Blood Product Distributors
7.5 Plasma Fractionation and Blood Product Customer Analysis
8 Plasma Fractionation and Blood Product Market Dynamics
8.1 Plasma Fractionation and Blood Product Industry Trends
8.2 Plasma Fractionation and Blood Product Market Drivers
8.3 Plasma Fractionation and Blood Product Market Challenges
8.4 Plasma Fractionation and Blood Product Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Plasma Fractionation and Blood Product Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Plasma Fractionation and Blood Product Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Plasma Fractionation and Blood Product Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Plasma Fractionation and Blood Product Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Plasma Fractionation and Blood Product Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Plasma Fractionation and Blood Product Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Plasma Fractionation and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Plasma Fractionation and Blood Product, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Plasma Fractionation and Blood Product, Product Type & Application
 Table 12. Global Key Manufacturers of Plasma Fractionation and Blood Product, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Plasma Fractionation and Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation and Blood Product as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Plasma Fractionation and Blood Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Plasma Fractionation and Blood Product Sales by Region (2020-2025) & (K Units)
 Table 18. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2020-2025)
 Table 19. Global Plasma Fractionation and Blood Product Sales by Region (2026-2031) & (K Units)
 Table 20. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2026-2031)
 Table 21. Global Plasma Fractionation and Blood Product Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2020-2025)
 Table 23. Global Plasma Fractionation and Blood Product Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2026-2031)
 Table 25. North America Plasma Fractionation and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Plasma Fractionation and Blood Product Sales by Country (2020-2025) & (K Units)
 Table 27. North America Plasma Fractionation and Blood Product Sales by Country (2026-2031) & (K Units)
 Table 28. North America Plasma Fractionation and Blood Product Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Plasma Fractionation and Blood Product Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Plasma Fractionation and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Plasma Fractionation and Blood Product Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Plasma Fractionation and Blood Product Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Plasma Fractionation and Blood Product Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Plasma Fractionation and Blood Product Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Plasma Fractionation and Blood Product Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Plasma Fractionation and Blood Product Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Plasma Fractionation and Blood Product Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Plasma Fractionation and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Plasma Fractionation and Blood Product Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Plasma Fractionation and Blood Product Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Plasma Fractionation and Blood Product Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Plasma Fractionation and Blood Product Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Plasma Fractionation and Blood Product Sales (K Units) by Type (2020-2025)
 Table 51. Global Plasma Fractionation and Blood Product Sales (K Units) by Type (2026-2031)
 Table 52. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2020-2025)
 Table 53. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2026-2031)
 Table 54. Global Plasma Fractionation and Blood Product Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Plasma Fractionation and Blood Product Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2020-2025)
 Table 57. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2026-2031)
 Table 58. Global Plasma Fractionation and Blood Product Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Plasma Fractionation and Blood Product Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Plasma Fractionation and Blood Product Sales (K Units) by Application (2020-2025)
 Table 61. Global Plasma Fractionation and Blood Product Sales (K Units) by Application (2026-2031)
 Table 62. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2020-2025)
 Table 63. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2026-2031)
 Table 64. Global Plasma Fractionation and Blood Product Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Plasma Fractionation and Blood Product Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2020-2025)
 Table 67. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2026-2031)
 Table 68. Global Plasma Fractionation and Blood Product Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Plasma Fractionation and Blood Product Price (US$/Unit) by Application (2026-2031)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Takeda Plasma Fractionation and Blood Product Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CSL Plasma Fractionation and Blood Product Product
 Table 79. CSL Recent Developments/Updates
 Table 80. Grifols Company Information
 Table 81. Grifols Description and Business Overview
 Table 82. Grifols Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Grifols Plasma Fractionation and Blood Product Product
 Table 84. Grifols Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Octapharma Plasma Fractionation and Blood Product Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. Kedrion Company Information
 Table 91. Kedrion Description and Business Overview
 Table 92. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Kedrion Plasma Fractionation and Blood Product Product
 Table 94. Kedrion Recent Developments/Updates
 Table 95. LFB Group Company Information
 Table 96. LFB Group Description and Business Overview
 Table 97. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. LFB Group Plasma Fractionation and Blood Product Product
 Table 99. LFB Group Recent Developments/Updates
 Table 100. Biotest Company Information
 Table 101. Biotest Description and Business Overview
 Table 102. Biotest Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Biotest Plasma Fractionation and Blood Product Product
 Table 104. Biotest Recent Developments/Updates
 Table 105. BPL Company Information
 Table 106. BPL Description and Business Overview
 Table 107. BPL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. BPL Plasma Fractionation and Blood Product Product
 Table 109. BPL Recent Developments/Updates
 Table 110. RAAS Company Information
 Table 111. RAAS Description and Business Overview
 Table 112. RAAS Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. RAAS Plasma Fractionation and Blood Product Product
 Table 114. RAAS Recent Developments/Updates
 Table 115. CBPO Company Information
 Table 116. CBPO Description and Business Overview
 Table 117. CBPO Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. CBPO Plasma Fractionation and Blood Product Product
 Table 119. CBPO Recent Developments/Updates
 Table 120. Hualan Bio Company Information
 Table 121. Hualan Bio Description and Business Overview
 Table 122. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hualan Bio Plasma Fractionation and Blood Product Product
 Table 124. Hualan Bio Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Plasma Fractionation and Blood Product Distributors List
 Table 128. Plasma Fractionation and Blood Product Customers List
 Table 129. Plasma Fractionation and Blood Product Market Trends
 Table 130. Plasma Fractionation and Blood Product Market Drivers
 Table 131. Plasma Fractionation and Blood Product Market Challenges
 Table 132. Plasma Fractionation and Blood Product Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Plasma Fractionation and Blood Product
 Figure 2. Global Plasma Fractionation and Blood Product Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Plasma Fractionation and Blood Product Market Share by Type: 2024 & 2031
 Figure 4. Coagulation Factor Product Picture
 Figure 5. Immune Globulin Product Picture
 Figure 6. Albumin Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Plasma Fractionation and Blood Product Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Plasma Fractionation and Blood Product Market Share by Application: 2024 & 2031
 Figure 10. Immunology
 Figure 11. Hematology
 Figure 12. Other
 Figure 13. Global Plasma Fractionation and Blood Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Plasma Fractionation and Blood Product Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Plasma Fractionation and Blood Product Sales (2020-2031) & (K Units)
 Figure 16. Global Plasma Fractionation and Blood Product Average Price (US$/Unit) & (2020-2031)
 Figure 17. Plasma Fractionation and Blood Product Report Years Considered
 Figure 18. Plasma Fractionation and Blood Product Sales Share by Manufacturers in 2024
 Figure 19. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Plasma Fractionation and Blood Product Players: Market Share by Revenue in Plasma Fractionation and Blood Product in 2024
 Figure 21. Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Plasma Fractionation and Blood Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Plasma Fractionation and Blood Product Sales Market Share by Country (2020-2031)
 Figure 24. North America Plasma Fractionation and Blood Product Revenue Market Share by Country (2020-2031)
 Figure 25. United States Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Plasma Fractionation and Blood Product Sales Market Share by Country (2020-2031)
 Figure 28. Europe Plasma Fractionation and Blood Product Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Plasma Fractionation and Blood Product Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Plasma Fractionation and Blood Product Revenue Market Share by Region (2020-2031)
 Figure 36. China Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Plasma Fractionation and Blood Product Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Plasma Fractionation and Blood Product Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Plasma Fractionation and Blood Product Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Plasma Fractionation and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Plasma Fractionation and Blood Product by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Plasma Fractionation and Blood Product by Type (2020-2031)
 Figure 57. Global Plasma Fractionation and Blood Product Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Plasma Fractionation and Blood Product by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Plasma Fractionation and Blood Product by Application (2020-2031)
 Figure 60. Global Plasma Fractionation and Blood Product Price (US$/Unit) by Application (2020-2031)
 Figure 61. Plasma Fractionation and Blood Product Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart